Search Abstracts Program

Session 93   Poster Session Mitochondrial Toxicity/Hyperlactatemia 4:30-6:30 pm 4E-F

Click on the to view the poster for an abstract.

707-T.	Antiretroviral Regimen-Dependent Mitochondrial DNA Depletion in Clinical Samples from the SWATCH Trial H. Côté*1, E. Negredo2, L. Ruiz2, S. Langridge1, Z. Brumme1, J. Martínez-Picado2, M. O’Shaughnessy1, P. R. Harrigan1, B. Clotet2, and J. Montaner1 1British Columbia Ctr. for Excellence in HIV/AIDS, Vancouver, Canada and 2IrsiCaixa Fndn., Univ. Hosp. Germans Trias i Pujol, Badalona, Spain Add to Itinerary
708-T.	Mitochondrial Toxicity of NRTIs: In Vitro Assessment and Comparison with Tenofovir G. Birkus, M .J. M. Hitchcock, and T. Cihlar* Gilead Sci., Foster City, CA Add to Itinerary
709-T.	Usefulness of Routine Lactate Measurement to Prevent Lactic Acidosis: Evaluation of a Protocol K. Brinkman*, N. Troost, L. Schrijnders, R. Regez, M. Treskes, S. Vrouenraets, H. Weigel, and P. Frissen Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands Add to Itinerary
710-T.	Elevated Lactate Levels Are Uncommon, even in Heavily Preetreated HIV-Infected Subjects G. A. McComsey*1,2, L. Yau3, H. Southwell2, B. Gripshover2, R. Asaad2, H. Valdez2, R. Salata2, and M. Lederman2 1Rainbow Babies and Children's Hosp., Cleveland, OH; 2Case Western Reserve Univ., Cleveland, OH; and 3GlaxoSmithKline, Res. Triangle Park, NC Add to Itinerary
711-T.	Asymptomatic Hyperlactatemia (HL) in HIV-Infected Patients Receiving Nucleoside Analogues (NA)-Containing HAART: Prevalence, Risk Factors, and Outcome A. Antela*, S. Moreno, J. Rubí, E. Pallarés, M. Pumares, J. L. Casado, M. J. Pérez-Elías, F. Dronda, A. Moreno, and M. E. Moreno Ramón y Cajal Hosp., Madrid, Spain Add to Itinerary

---